The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Naloxone-Global Market Insights and Sales Trends 2025
Synopsis
Naloxone drug in this report.
The global Naloxone market size is expected to reach US$ 33840 million by 2029, growing at a CAGR of 2.9% from 2023 to 2029. The market is mainly driven by the significant applications of Naloxone in various end use industries. The expanding demands from the Drug Store, Hospital Pharmacies and Online,, are propelling Naloxone market. Spray Forms, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injectable Forms segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Naloxone market, driven by demand from China, the second largest economy with some signs of stabilising, the Naloxone market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Naloxone, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Naloxone market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Naloxone market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Naloxone sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Naloxone covered in this report include ADAPT Pharma, Amphastar Pharmaceuticals, Pfizer, Kaleo, Sandoz, Amneal Pharmaceuticals, West Ward Pharmaceuticals and Mylan, etc.
The global Naloxone market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
ADAPT Pharma
Amphastar Pharmaceuticals
Pfizer
Kaleo
Sandoz
Amneal Pharmaceuticals
West Ward Pharmaceuticals
Mylan
Global Naloxone market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Naloxone market, Segment by Type:
Spray Forms
Injectable Forms
Global Naloxone market, by Application
Drug Store
Hospital Pharmacies
Online
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Naloxone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Naloxone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Naloxone drug in this report.
The global Naloxone market size is expected to reach US$ 33840 million by 2029, growing at a CAGR of 2.9% from 2023 to 2029. The market is mainly driven by the significant applications of Naloxone in various end use industries. The expanding demands from the Drug Store, Hospital Pharmacies and Online,, are propelling Naloxone market. Spray Forms, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injectable Forms segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Naloxone market, driven by demand from China, the second largest economy with some signs of stabilising, the Naloxone market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Naloxone, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Naloxone market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Naloxone market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Naloxone sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Naloxone covered in this report include ADAPT Pharma, Amphastar Pharmaceuticals, Pfizer, Kaleo, Sandoz, Amneal Pharmaceuticals, West Ward Pharmaceuticals and Mylan, etc.
The global Naloxone market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
ADAPT Pharma
Amphastar Pharmaceuticals
Pfizer
Kaleo
Sandoz
Amneal Pharmaceuticals
West Ward Pharmaceuticals
Mylan
Global Naloxone market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Naloxone market, Segment by Type:
Spray Forms
Injectable Forms
Global Naloxone market, by Application
Drug Store
Hospital Pharmacies
Online
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Naloxone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Naloxone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Naloxone Market Overview
1.1 Naloxone Product Overview
1.2 Naloxone Market Segment by Type
1.2.1 Spray Forms
1.2.2 Injectable Forms
1.3 Global Naloxone Market Size by Type
1.3.1 Global Naloxone Market Size Overview by Type (2018-2029)
1.3.2 Global Naloxone Historic Market Size Review by Type (2018-2023)
1.3.3 Global Naloxone Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Naloxone Sales Breakdown by Type (2018-2023)
1.4.2 Europe Naloxone Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Naloxone Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Naloxone Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Naloxone Sales Breakdown by Type (2018-2023)
2 Global Naloxone Market Competition by Company
2.1 Global Top Players by Naloxone Sales (2018-2023)
2.2 Global Top Players by Naloxone Revenue (2018-2023)
2.3 Global Top Players by Naloxone Price (2018-2023)
2.4 Global Top Manufacturers Naloxone Manufacturing Base Distribution, Sales Area, Product Type
2.5 Naloxone Market Competitive Situation and Trends
2.5.1 Naloxone Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Naloxone Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Naloxone as of 2022)
2.7 Date of Key Manufacturers Enter into Naloxone Market
2.8 Key Manufacturers Naloxone Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Naloxone Status and Outlook by Region
3.1 Global Naloxone Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Naloxone Historic Market Size by Region
3.2.1 Global Naloxone Sales in Volume by Region (2018-2023)
3.2.2 Global Naloxone Sales in Value by Region (2018-2023)
3.2.3 Global Naloxone Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Naloxone Forecasted Market Size by Region
3.3.1 Global Naloxone Sales in Volume by Region (2024-2029)
3.3.2 Global Naloxone Sales in Value by Region (2024-2029)
3.3.3 Global Naloxone Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Naloxone by Application
4.1 Naloxone Market Segment by Application
4.1.1 Drug Store
4.1.2 Hospital Pharmacies
4.1.3 Online
4.2 Global Naloxone Market Size by Application
4.2.1 Global Naloxone Market Size Overview by Application (2018-2029)
4.2.2 Global Naloxone Historic Market Size Review by Application (2018-2023)
4.2.3 Global Naloxone Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Naloxone Sales Breakdown by Application (2018-2023)
4.3.2 Europe Naloxone Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Naloxone Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Naloxone Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Naloxone Sales Breakdown by Application (2018-2023)
5 North America Naloxone by Country
5.1 North America Naloxone Historic Market Size by Country
5.1.1 North America Naloxone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Naloxone Sales in Volume by Country (2018-2023)
5.1.3 North America Naloxone Sales in Value by Country (2018-2023)
5.2 North America Naloxone Forecasted Market Size by Country
5.2.1 North America Naloxone Sales in Volume by Country (2024-2029)
5.2.2 North America Naloxone Sales in Value by Country (2024-2029)
6 Europe Naloxone by Country
6.1 Europe Naloxone Historic Market Size by Country
6.1.1 Europe Naloxone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Naloxone Sales in Volume by Country (2018-2023)
6.1.3 Europe Naloxone Sales in Value by Country (2018-2023)
6.2 Europe Naloxone Forecasted Market Size by Country
6.2.1 Europe Naloxone Sales in Volume by Country (2024-2029)
6.2.2 Europe Naloxone Sales in Value by Country (2024-2029)
7 Asia-Pacific Naloxone by Region
7.1 Asia-Pacific Naloxone Historic Market Size by Region
7.1.1 Asia-Pacific Naloxone Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Naloxone Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Naloxone Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Naloxone Forecasted Market Size by Region
7.2.1 Asia-Pacific Naloxone Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Naloxone Sales in Value by Region (2024-2029)
8 Latin America Naloxone by Country
8.1 Latin America Naloxone Historic Market Size by Country
8.1.1 Latin America Naloxone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Naloxone Sales in Volume by Country (2018-2023)
8.1.3 Latin America Naloxone Sales in Value by Country (2018-2023)
8.2 Latin America Naloxone Forecasted Market Size by Country
8.2.1 Latin America Naloxone Sales in Volume by Country (2024-2029)
8.2.2 Latin America Naloxone Sales in Value by Country (2024-2029)
9 Middle East and Africa Naloxone by Country
9.1 Middle East and Africa Naloxone Historic Market Size by Country
9.1.1 Middle East and Africa Naloxone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Naloxone Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Naloxone Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Naloxone Forecasted Market Size by Country
9.2.1 Middle East and Africa Naloxone Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Naloxone Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 ADAPT Pharma
10.1.1 ADAPT Pharma Company Information
10.1.2 ADAPT Pharma Introduction and Business Overview
10.1.3 ADAPT Pharma Naloxone Sales, Revenue and Gross Margin (2018-2023)
10.1.4 ADAPT Pharma Naloxone Products Offered
10.1.5 ADAPT Pharma Recent Development
10.2 Amphastar Pharmaceuticals
10.2.1 Amphastar Pharmaceuticals Company Information
10.2.2 Amphastar Pharmaceuticals Introduction and Business Overview
10.2.3 Amphastar Pharmaceuticals Naloxone Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Amphastar Pharmaceuticals Naloxone Products Offered
10.2.5 Amphastar Pharmaceuticals Recent Development
10.3 Pfizer
10.3.1 Pfizer Company Information
10.3.2 Pfizer Introduction and Business Overview
10.3.3 Pfizer Naloxone Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Pfizer Naloxone Products Offered
10.3.5 Pfizer Recent Development
10.4 Kaleo
10.4.1 Kaleo Company Information
10.4.2 Kaleo Introduction and Business Overview
10.4.3 Kaleo Naloxone Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Kaleo Naloxone Products Offered
10.4.5 Kaleo Recent Development
10.5 Sandoz
10.5.1 Sandoz Company Information
10.5.2 Sandoz Introduction and Business Overview
10.5.3 Sandoz Naloxone Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Sandoz Naloxone Products Offered
10.5.5 Sandoz Recent Development
10.6 Amneal Pharmaceuticals
10.6.1 Amneal Pharmaceuticals Company Information
10.6.2 Amneal Pharmaceuticals Introduction and Business Overview
10.6.3 Amneal Pharmaceuticals Naloxone Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Amneal Pharmaceuticals Naloxone Products Offered
10.6.5 Amneal Pharmaceuticals Recent Development
10.7 West Ward Pharmaceuticals
10.7.1 West Ward Pharmaceuticals Company Information
10.7.2 West Ward Pharmaceuticals Introduction and Business Overview
10.7.3 West Ward Pharmaceuticals Naloxone Sales, Revenue and Gross Margin (2018-2023)
10.7.4 West Ward Pharmaceuticals Naloxone Products Offered
10.7.5 West Ward Pharmaceuticals Recent Development
10.8 Mylan
10.8.1 Mylan Company Information
10.8.2 Mylan Introduction and Business Overview
10.8.3 Mylan Naloxone Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Mylan Naloxone Products Offered
10.8.5 Mylan Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Naloxone Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Naloxone Industrial Chain Analysis
11.4 Naloxone Market Dynamics
11.4.1 Naloxone Industry Trends
11.4.2 Naloxone Market Drivers
11.4.3 Naloxone Market Challenges
11.4.4 Naloxone Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Naloxone Distributors
12.3 Naloxone Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
